WntResearch Investor Relations Material
Latest events
Q3 2022
WntResearch
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from WntResearch
Access all reports
WntResearch is a biotechnology company specializing in oncology, focusing on the development of therapies aimed at preventing the spread of cancer. The company's approach involves targeting the metastatic process by researching the endogenous protein WNT5A, which plays a critical role in the mobility and spread of tumor cells within the body. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
WNT
Country
🇸🇪 Sweden